<!DOCTYPE html>
<html lang="it">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0, user-scalable=yes">
    <meta name="description" content="Guida rapida alle emergenze cardiologiche - Tachiaritmie, Bradiaritmie, Ipertensione">
    <meta name="theme-color" content="#d32f2f">
    <title>Emergenze Cardiologiche - Guida Mobile</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
            -webkit-tap-highlight-color: transparent;
        }
        
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, sans-serif;
            font-size: 14px;
            line-height: 1.4;
            background: #f5f5f5;
            color: #212121;
            padding-bottom: 60px;
        }
          .back-link {
            text-align: center;
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid #e9ecef;
        }
        
        .back-link a {
            color: #3498db;
            text-decoration: none;
            font-size: 1.1em;
            font-weight: bold;
        }
        
        .back-link a:hover {
            text-decoration: underline;
        }
        
        /* Container principale responsive */
        .main-container {
            max-width: 100%;
            margin: 0 auto;
            background: white;
        }
        
        /* Card responsive per mobile */
        .card-side {
            width: 100%;
            min-height: auto;
            padding: 12px;
            margin-bottom: 8px;
            background: white;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
            border-radius: 8px;
            overflow: hidden;
        }
        
        @media (min-width: 768px) {
            .main-container {
                max-width: 768px;
                padding: 16px;
            }
            
            .card-side {
                padding: 16px;
                margin-bottom: 16px;
            }
        }
        
        .header {
            background: linear-gradient(135deg, #d32f2f, #f44336);
            color: white;
            text-align: center;
            font-weight: bold;
            font-size: 16px;
            padding: 12px;
            margin: -12px -12px 12px -12px;
            border-radius: 8px 8px 0 0;
            position: sticky;
            top: 0;
            z-index: 10;
        }
        
        @media (min-width: 768px) {
            .header {
                font-size: 18px;
                padding: 16px;
                margin: -16px -16px 16px -16px;
            }
        }
        
        .section {
            margin-bottom: 12px;
            border: 1px solid #e0e0e0;
            border-radius: 6px;
            padding: 10px;
            background: #fafafa;
        }
        
        .section-title {
            color: white;
            font-weight: bold;
            font-size: 14px;
            padding: 8px;
            margin: -10px -10px 10px -10px;
            text-align: center;
            border-radius: 6px 6px 0 0;
        }
        
        /* Colori sezioni ottimizzati per accessibilit√† */
        .urgent { background: linear-gradient(135deg, #ff5722, #ff6b6b); }
        .success { background: linear-gradient(135deg, #388e3c, #4caf50); }
        .warning { background: linear-gradient(135deg, #f57c00, #ff9800); }
        .purple { background: linear-gradient(135deg, #7b1fa2, #9c27b0); }
        .teal { background: linear-gradient(135deg, #00796b, #009688); }
        
        .dosage {
            background: #fff9c4;
            padding: 10px;
            font-weight: 500;
            border-left: 4px solid #ffc107;
            margin: 8px 0;
            font-size: 13px;
            border-radius: 4px;
            line-height: 1.5;
        }
        
        ul {
            list-style: none;
            padding-left: 8px;
            margin: 8px 0;
        }
        
        li {
            padding: 4px 0;
            font-size: 13px;
            line-height: 1.4;
        }
        
        li::before {
            content: "‚Ä¢ ";
            color: #1976d2;
            font-weight: bold;
            margin-right: 4px;
        }
        
        .contraindication::before {
            content: "‚úó ";
            color: #d32f2f;
        }
        
        .indication::before {
            content: "‚úì ";
            color: #388e3c;
        }
        
        .small-text {
            font-size: 12px;
            line-height: 1.5;
            color: #424242;
        }
        
        .bold {
            font-weight: 600;
        }
        
        /* Tabelle responsive */
        .table-container {
            overflow-x: auto;
            margin: 8px 0;
            -webkit-overflow-scrolling: touch;
        }
        
        table {
            width: 100%;
            min-width: 300px;
            border-collapse: collapse;
            font-size: 12px;
            margin: 8px 0;
        }
        
        td, th {
            border: 1px solid #e0e0e0;
            padding: 6px;
            text-align: left;
        }
        
        th {
            background: #e3f2fd;
            font-weight: 600;
            position: sticky;
            top: 0;
            z-index: 5;
        }
        
        /* Grid responsive */
        .grid-2 {
            display: grid;
            grid-template-columns: 1fr;
            gap: 12px;
            font-size: 13px;
        }
        
        @media (min-width: 480px) {
            .grid-2 {
                grid-template-columns: 1fr 1fr;
            }
        }
        
        /* Navigazione sticky */
        .nav-container {
            position: fixed;
            bottom: 0;
            left: 0;
            right: 0;
            background: white;
            box-shadow: 0 -2px 10px rgba(0,0,0,0.1);
            z-index: 100;
            display: flex;
            justify-content: space-around;
            padding: 8px;
        }
        
        .nav-button {
            flex: 1;
            padding: 8px 4px;
            margin: 0 2px;
            background: linear-gradient(135deg, #1976d2, #2196f3);
            color: white;
            border: none;
            border-radius: 6px;
            font-size: 11px;
            font-weight: 500;
            cursor: pointer;
            transition: transform 0.2s, box-shadow 0.2s;
        }
        
        .nav-button:active {
            transform: scale(0.95);
        }
        
        .nav-button:hover {
            box-shadow: 0 2px 8px rgba(0,0,0,0.2);
        }
        
        /* Contatti migliorati */
        .contatti {
            background: linear-gradient(135deg, #f5f5f5, #e0e0e0);
            padding: 16px;
            margin: 16px 0;
            border-radius: 8px;
            text-align: center;
            line-height: 1.8;
        }
        
        .contatti a {
            color: #1976d2;
            text-decoration: none;
            font-weight: 500;
            transition: color 0.3s;
        }
        
        .contatti a:hover {
            color: #0d47a1;
            text-decoration: underline;
        }
        
        .social-links {
            display: flex;
            justify-content: center;
            gap: 16px;
            margin-top: 12px;
            flex-wrap: wrap;
        }
        
        .social-link {
            display: inline-flex;
            align-items: center;
            gap: 8px;
            padding: 8px 12px;
            background: white;
            border-radius: 6px;
            transition: transform 0.2s, box-shadow 0.2s;
        }
        
        .social-link:hover {
            transform: translateY(-2px);
            box-shadow: 0 4px 8px rgba(0,0,0,0.1);
        }
        
        .social-link img {
            width: 24px;
            height: 24px;
        }
        
        /* Miglioramenti per touch */
        @media (pointer: coarse) {
            .nav-button {
                padding: 10px 6px;
                font-size: 12px;
            }
            
            .section {
                padding: 12px;
            }
            
            .dosage {
                padding: 12px;
            }
        }
        
        /* Print styles */
        @media print {
            .nav-container {
                display: none;
            }
            
            body {
                padding-bottom: 0;
                background: white;
            }
            
            .card-side {
                page-break-after: always;
                box-shadow: none;
                border: 1px solid #000;
            }
            
            .header {
                position: static;
            }
        }
        
        /* Smooth scroll */
        html {
            scroll-behavior: smooth;
        }
        
        /* Focus styles per accessibilit√† */
        button:focus,
        a:focus {
            outline: 2px solid #1976d2;
            outline-offset: 2px;
        }
    </style>
</head>
<body>
    <div class="main-container">
        <!-- FACCIATA 1 - TACHIARITMIE -->
        <div class="card-side" id="tachiaritmie">
            <div class="header">TACHIARITMIE - CONTROLLO FREQUENZA</div>
            
            <!-- MANOVRE VAGALI -->
            <div class="section">
                <div class="section-title urgent">üîß MANOVRE VAGALI (Prima Linea)</div>
                <div class="small-text">
                    <strong>1. VALSALVA MODIFICATA (pi√π efficace):</strong><br>
                    ‚Ä¢ Paziente seduto: soffia 15 secondi (glottide chiusa)<br>
                    ‚Ä¢ Immediatamente: supino + gambe sollevate<br>
                    ‚Ä¢ Tubicino con estremit√† legata se non riesce<br><br>
                    
                    <strong>2. MASSAGGIO CAROTIDEO:</strong><br>
                    ‚Ä¢ Monolaterale sotto angolo mandibolare<br>
                    ‚Ä¢ Funziona meglio su FC, meno su PA<br>
                    ‚Ä¢ Migliore in tachicardie sinusali<br><br>
                    
                    <strong>3. COMPRESSIONE BULBI OCULARI:</strong><br>
                    ‚Ä¢ Bilaterale, occhi chiusi, 10-15 secondi<br>
                    ‚Ä¢ Funziona meglio sulla PA
                </div>
            </div>

            <!-- BETA-BLOCCANTI -->
            <div class="section">
                <div class="section-title success">Œ≤ METOPROLOLO (Seloken)</div>
                <div class="dosage">
                    <strong>BOLO EV:</strong><br>
                    ‚Ä¢ 2,5-5mg EV lento in 2 minuti<br>
                    ‚Ä¢ Ripetibile ogni 10 minuti<br>
                    ‚Ä¢ Massimo: 15mg totali (3 fiale)<br>
                    ‚Ä¢ Se no risposta dopo 2 tentativi ‚Üí inutile continuare
                </div>
                <div class="dosage">
                    <strong>INFUSIONE CONTINUA:</strong><br>
                    ‚Ä¢ 1 fiala in 95ml SF<br>
                    ‚Ä¢ Velocit√†: 1-50ml/h<br>
                    ‚Ä¢ Solo se risposta positiva al bolo
                </div>
                <div class="dosage">
                    <strong>TERAPIA ORALE:</strong><br>
                    ‚Ä¢ 100-200mg: 1-4cp/die (max 400mg)<br>
                    ‚Ä¢ Indicazioni: ipertensione, tachicardie, ipertiroidismo, IMA
                </div>
            </div>

            <!-- VERAPAMIL -->
            <div class="section">
                <div class="section-title warning">üíä VERAPAMIL (Isoptin)</div>
                <div class="dosage">
                    <strong>BOLO EV:</strong><br>
                    ‚Ä¢ 5-10mg EV lento in 2-3 minuti<br>
                    ‚Ä¢ Ripetibile dopo 15-30 minuti<br>
                    ‚Ä¢ Dose massima: 20mg (4 fiale)
                </div>
                <div class="dosage">
                    <strong>INFUSIONE CONTINUA:</strong><br>
                    ‚Ä¢ 10 fiale in 230ml SF<br>
                    ‚Ä¢ Da 12,5ml/h (2,5mg/h) a 35ml/h (7,5mg/h)
                </div>
                <div class="small-text">
                    <strong>‚ö†Ô∏è IMPORTANTE:</strong> NON associare mai con Amiodarone!<br>
                    <strong>Orale:</strong> 80mg√ó3/die (stroke: ore 8-13-20) max 240mg/die
                </div>
            </div>

            <!-- CONTROINDICAZIONI TACHIARITMIE -->
            <div class="section">
                <div class="section-title urgent">‚ö†Ô∏è CONTROINDICAZIONI Œ≤-BLOCCANTI & VERAPAMIL</div>
                <div class="grid-2">
                    <div>
                        <strong>Œ≤-BLOCCANTI:</strong>
                        <ul>
                            <li class="contraindication">Asma e BPCO</li>
                            <li class="contraindication">BAV 2-3¬∞</li>
                            <li class="contraindication">Shock/ipotensione severa</li>
                            <li class="contraindication">Scompenso severo</li>
                        </ul>
                    </div>
                    <div>
                        <strong>VERAPAMIL:</strong>
                        <ul>
                            <li class="contraindication">BAV 2-3¬∞, WPW</li>
                            <li class="contraindication">FE <35%</li>
                            <li class="contraindication">Shock cardiogeno</li>
                            <li class="contraindication">Miopatia di Duchenne</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>

        <!-- FACCIATA 2 - DIGITALICI & ANTIARITMICI -->
        <div class="card-side" id="antiaritmici">
            <div class="header">DIGITALICI & ANTIARITMICI AVANZATI</div>
            
            <!-- DIGOSSINA -->
            <div class="section">
                <div class="section-title success">üíä DIGOSSINA (Lanoxin)</div>
                <div class="small-text">
                    <strong>Indicazioni:</strong> Tachiaritmie + scompenso, shock cardiogeno<br>
                    <strong>‚ö†Ô∏è MAI in bolo puro!</strong> Rischio ipertensione e aritmie
                </div>
                <div class="dosage">
                    <strong>DIGITALIZZAZIONE EV RAPIDA (Carico):</strong><br>
                    <strong>Schema A:</strong> 0,5mg/100ml SF/20min ‚Üí 0,25mg dopo 4h ‚Üí 0,25mg dopo 8h<br>
                    <strong>Schema B:</strong> 0,25mg/100ml SF/20min ‚Üí 0,125mg dopo 4h ‚Üí 0,125mg dopo 8h<br>
                    <strong>Esempio timing:</strong> 1fl ore 8 ‚Üí ¬Ωfl ore 12 ‚Üí ¬Ωfl ore 16
                </div>
                <div class="dosage">
                    <strong>MANTENIMENTO:</strong><br>
                    ‚Ä¢ 20% della dose di carico nelle 24h<br>
                    ‚Ä¢ 0,125-0,5mg/die (aggiustare per et√†/funzione renale)<br>
                    ‚Ä¢ Dose orale = ‚Öì di quella EV
                </div>
                <div class="dosage">
                    <strong>DIGITALIZZAZIONE ORALE:</strong><br>
                    ‚Ä¢ Rapida: 0,75-1,5mg dose singola<br>
                    ‚Ä¢ Lenta: 0,25-0,75mg/die (<70aa), 0,125mg/die (>70aa/IR)
                </div>
            </div>

            <!-- AMIODARONE -->
            <div class="section">
                <div class="section-title warning">‚ö° AMIODARONE (Cordarone)</div>
                <div class="small-text">
                    <strong>‚ö†Ô∏è IMPORTANTE:</strong> Solo in GLUCOSATA! NON con Verapamil!<br>
                    <strong>Uso:</strong> Cardioversione, ultima scelta per controllo FC
                </div>
                <div class="dosage">
                    <strong>CARICO EV:</strong><br>
                    ‚Ä¢ 300mg (2fl) in 100ml glucosata in 20 minuti
                </div>
                <div class="dosage">
                    <strong>MANTENIMENTO EV:</strong><br>
                    ‚Ä¢ 900mg (6fl) in 250ml glucosata a 10-20ml/h<br>
                    ‚Ä¢ Alternativa: 6fl in 500ml a 30ml/h√ó6h poi 15ml/h
                </div>
                <div class="dosage">
                    <strong>TERAPIA ORALE:</strong><br>
                    ‚Ä¢ Carico: 600mg/die√ó7gg ‚Üí 400mg/die√ó7gg<br>
                    ‚Ä¢ Mantenimento: 200mg/die (100-400mg)<br>
                    ‚Ä¢ Possibile schema: 5gg/settimana o 2-3 sett/mese
                </div>
            </div>

            <!-- CONTROINDICAZIONI AVANZATE -->
            <div class="section">
                <div class="section-title urgent">‚ö†Ô∏è CONTROINDICAZIONI DIGITALICI & AMIODARONE</div>
                <div class="grid-2">
                    <div>
                        <strong>DIGOSSINA:</strong>
                        <ul>
                            <li class="contraindication">BAV 2-3¬∞, WPW</li>
                            <li class="contraindication">TV, FV</li>
                            <li class="contraindication">CMI ostruttiva</li>
                            <li class="contraindication">IR grave</li>
                            <li class="contraindication">Ipokaliemia</li>
                        </ul>
                    </div>
                    <div>
                        <strong>AMIODARONE:</strong>
                        <ul>
                            <li class="contraindication">BAV 2-3¬∞</li>
                            <li class="contraindication">Blocco trifascicolare</li>
                            <li class="contraindication">Distiroidismi</li>
                            <li class="contraindication">Ipotensione severa</li>
                        </ul>
                    </div>
                </div>
                <div class="small-text">
                    <strong>Effetti collaterali Amiodarone:</strong> Ipotiroidismo, fibrosi polmonare, ipotensione<br>
                    <strong>‚ö†Ô∏è Rischio stroke:</strong> Cardioversione senza anticoagulazione se trombi intracavitari
                </div>
            </div>

            <!-- BISOPROLOLO -->
            <div class="section">
                <div class="section-title teal">üíä BISOPROLOLO (Cardicor) - Terapia Orale</div>
                <div class="small-text">
                    <strong>Indicazioni:</strong> Sostituto orale del Seloken, terapia domiciliare tachicardie
                </div>
                <div class="dosage">
                    <strong>TITOLAZIONE GRADUALE:</strong><br>
                    ‚Ä¢ Start: 1,25mg√ó7gg ‚Üí 2,5mg√ó7gg ‚Üí 3,75mg ‚Üí 5mg ‚Üí 7,25mg<br>
                    ‚Ä¢ Massimo: 10mg/die in monosomministrazione<br>
                    ‚Ä¢ ‚ö†Ô∏è NON associare con Clonidina (‚Üìinotropismo)
                </div>
            </div>
        </div>

        <!-- FACCIATA 3 - BRADIARITMIE -->
        <div class="card-side" id="bradiaritmie">
            <div class="header">BRADIARITMIE - TRATTARE SE FC <40bpm</div>
            
            <!-- ATROPINA -->
            <div class="section">
                <div class="section-title urgent">üíä ATROPINA (Prima Scelta)</div>
                <div class="dosage">
                    <strong>DOSAGGIO:</strong><br>
                    ‚Ä¢ 0,5-1mg EV bolo rapido<br>
                    ‚Ä¢ Ripetibile ogni 3-5 minuti<br>
                    ‚Ä¢ Dose massima: 3mg (3-6 fiale)
                </div>
                <div class="small-text">
                    <strong>Controindicazioni (relative in bradicardia severa):</strong><br>
                    ‚Ä¢ Glaucoma ad angolo chiuso ‚Ä¢ MRGE ‚Ä¢ Stenosi pilorica<br>
                    ‚Ä¢ Ostruzione GI ‚Ä¢ Colite ulcerosa ‚Ä¢ Ipertrofia prostatica<br>
                    ‚Ä¢ Ileo paralitico ‚Ä¢ Atonia intestinale ‚Ä¢ Miastenia gravis
                </div>
            </div>

            <!-- EFEDRINA -->
            <div class="section">
                <div class="section-title success">‚ö° EFEDRINA (Post-Anestesia)</div>
                <div class="small-text">
                    <strong>Indicazioni:</strong> Ipotensione + bradicardia post-anestesia (es. trombectomia)<br>
                    <strong>Vantaggio:</strong> Azione rapida combinata su pressione e frequenza
                </div>
                <div class="dosage">
                    <strong>FIALE 25mg/1ml:</strong><br>
                    ‚Ä¢ Bolo: 25mg (1 fiala) fino a 50mg
                </div>
                <div class="dosage">
                    <strong>FIALE 30mg/10ml (3mg/ml):</strong><br>
                    ‚Ä¢ Bolo: 1-2ml (3-6mg) EV lento, max 3ml (9mg)<br>
                    ‚Ä¢ Ripetibile ogni 3-4 min fino a 1 fiala (30mg)<br>
                    ‚Ä¢ Dose max 24h: 5 fiale (150mg)
                </div>
                <div class="small-text">
                    <strong>Controindicazioni:</strong> I-MAO (<14 giorni), altri simpaticomimetici
                </div>
            </div>

            <!-- ADRENALINA -->
            <div class="section">
                <div class="section-title urgent">üöë ADRENALINA</div>
                <div class="dosage">
                    <strong>BRADICARDIA SEVERA/ARRESTO:</strong><br>
                    ‚Ä¢ 1mg (1 fiala) EV ogni 3-5 minuti<br>
                    ‚Ä¢ Via endotracheale: 2 fiale
                </div>
                <div class="dosage">
                    <strong>ANAFILASSI:</strong><br>
                    ‚Ä¢ 0,5mg (¬Ω fiala) EV ogni 3-5 minuti<br>
                    ‚Ä¢ Possibile anche IM: 1mg ogni 10 min
                </div>
                <div class="small-text">
                    <strong>Pediatrico:</strong> 0,1mg/kg
                </div>
            </div>

            <!-- DOPAMINA -->
            <div class="section">
                <div class="section-title warning">üíâ DOPAMINA - Infusione Continua</div>
                <div class="dosage">
                    <strong>PREPARAZIONE:</strong><br>
                    ‚Ä¢ 2 fiale (200mg) in 500ml SF/glucosata/Ringer<br>
                    ‚Ä¢ Concentrazione finale: 0,8Œºg/ml<br>
                    ‚Ä¢ Dose start: 5Œºg/kg/min ‚Üí max 20Œºg/kg/min
                </div>
                <div class="table-container">
                    <table>
                        <tr><th>Peso</th><th>5Œºg/kg/min</th><th>10Œºg/kg/min</th><th>20Œºg/kg/min</th></tr>
                        <tr><td>60kg</td><td>22,5ml/h</td><td>45ml/h</td><td>90ml/h</td></tr>
                        <tr><td>70kg</td><td>26,5ml/h</td><td>53ml/h</td><td>106ml/h</td></tr>
                        <tr><td>80kg</td><td>30ml/h</td><td>60ml/h</td><td>120ml/h</td></tr>
                    </table>
                </div>
                <div class="small-text">
                    <strong>Per dosi pi√π concentrate:</strong> 4fl in 500ml (dimezza le velocit√†)
                </div>
            </div>

            <!-- ISOPRENALINA -->
            <div class="section">
                <div class="section-title purple">‚ö° ISOPRENALINA</div>
                <div class="small-text">
                    <strong>Indicazioni:</strong> BAV totale, arresto cardiaco
                </div>
                <div class="dosage">
                    <strong>BOLO:</strong><br>
                    ‚Ä¢ IM/SC: 1 fiala, poi dose variabile 1/10-5 fiale dopo 4h<br>
                    ‚Ä¢ EV: 1 fiala diluita in 10ml SF bolo rapido
                </div>
                <div class="dosage">
                    <strong>INFUSIONE (Shock cardiogeno + bassa FC):</strong><br>
                    ‚Ä¢ 10 fiale in 500ml SF da 8-75ml/h<br>
                    ‚Ä¢ Se serve 5-20Œºg/min: 10fl in 250ml (dimezza velocit√†)
                </div>
            </div>
        </div>

        <!-- FACCIATA 4 - IPERTENSIONE & TERAPIA ORALE -->
        <div class="card-side" id="ipertensione">
            <div class="header">IPERTENSIONE - CRISI & TERAPIA ORALE</div>
            
            <!-- CRISI IPERTENSIVA EV -->
            <div class="section">
                <div class="section-title urgent">üìà CRISI IPERTENSIVA - Farmaci EV</div>
                <div class="grid-2">
                    <div>
                        <div class="dosage">
                            <strong>LABETALOLO:</strong><br>
                            Bolo: 10-20mg EV<br>
                            Inf: 2fl/160ml SF, 10-80ml/h<br>
                            <em>Ottimo se PA+FC elevate</em>
                        </div>
                        <div class="dosage">
                            <strong>URAPIDIL:</strong><br>
                            Bolo: 10-50mg EV<br>
                            Inf: 5fl/250ml SF, 10-40ml/h<br>
                            Max: 100mg/24h
                        </div>
                    </div>
                    <div>
                        <div class="dosage">
                            <strong>CLEVIDIPINA:</strong><br>
                            Start: 2-4ml/h, Max: 64ml/h<br>
                            Uso diretto fiala<br>
                            <em>Effetto 2-4min</em>
                        </div>
                        <div class="dosage">
                            <strong>CLONIDINA:</strong><br>
                            150Œºg/10ml SF, EV lento 10min<br>
                            Ripeti dopo 1h, Max: 600Œºg/24h
                        </div>
                    </div>
                </div>
                <div class="small-text"><strong>‚ö†Ô∏è Intake liquidi totale:</strong> ~60ml/h per infusioni combinate</div>
            </div>

            <!-- NITROGLICERINA -->
            <div class="section">
                <div class="section-title success">üíä NITROGLICERINA (Coronaropatie)</div>
                <div class="dosage">
                    <strong>FIALE 5mg/1,5ml:</strong> 2fl/250ml SF<br>
                    0,5mg/h‚Üí10ml/h | 1,5mg/h‚Üí30ml/h | 3mg/h‚Üí60ml/h | Max 6mg/h‚Üí120ml/h
                </div>
                <div class="small-text"><strong>Controindicazioni:</strong> Ictus acuto, emorragia cerebrale, glaucoma, ipovolemia</div>
            </div>

            <!-- ALGORITMO TERAPIA ORALE -->
            <div class="section">
                <div class="section-title">üéØ ALGORITMO TERAPIA ORALE</div>
                <div class="small-text"><strong>Target:</strong> PAS 120-140, PAD 70-80 mmHg | <strong>Trattare se:</strong> >140/90 (>130/85 se alto rischio)</div>
                <div class="dosage">
                    <strong>STEP 1:</strong> ACE-i/Sartano + Ca-antagonista/Diuretico<br>
                    <strong>STEP 2:</strong> ACE-i/Sartano + Ca-antagonista + Diuretico<br>
                    <strong>STEP 3:</strong> + Spironolattone/Œ±-bloccanti/Clonidina
                </div>
            </div>

            <!-- FARMACI ORALI PRINCIPALI -->
            <div class="section">
                <div class="section-title success">üíä FARMACI ORALI</div>
                <div class="table-container">
                    <table>
                        <tr><th>Farmaco</th><th>Start</th><th>Max</th><th>Note</th></tr>
                        <tr><td>Ramipril</td><td>2,5-5mg</td><td>10mg</td><td>1√ó/die</td></tr>
                        <tr><td>Amlodipina</td><td>5mg</td><td>10mg</td><td>1√ó/die</td></tr>
                        <tr><td>Olmesartan</td><td>10-20mg</td><td>40mg</td><td>1√ó/die</td></tr>
                        <tr><td>Candesartan</td><td>8-16mg</td><td>32mg</td><td>+Emicrania</td></tr>
                        <tr><td>Bisoprololo</td><td>1,25mg</td><td>10mg</td><td>Titolare</td></tr>
                        <tr><td>Spironolattone</td><td>25mg</td><td>100mg</td><td>Resistente</td></tr>
                        <tr><td>HCTZ</td><td>12,5mg</td><td>25mg</td><td>+ACE-i</td></tr>
                        <tr><td>Furosemide</td><td>25mg</td><td>75mg</td><td>eGFR<30</td></tr>
                    </table>
                </div>
            </div>

            <!-- DIURETICI PER eGFR -->
            <div class="section">
                <div class="section-title purple">üíß DIURETICI per eGFR</div>
                <div class="grid-2">
                    <div>
                        <strong>eGFR >45:</strong> Tiazidici (HCTZ 12,5-25mg), Prima scelta<br>
                        <strong>eGFR 30-45:</strong> Shift a diuretici ansa<br>
                        <strong>eGFR <30:</strong> Solo ansa ¬± Clortalidone
                    </div>
                    <div>
                        <strong>Risparmia K+:</strong> Canrenone 50-200mg<br>
                        <strong>Controindicazioni:</strong> eGFR <30 per K+, allergia sulfamidici per HCTZ<br>
                        <strong>Effetti:</strong> ‚ÜìK+, ‚Üëuricemia, ‚ÜëCa++
                    </div>
                </div>
            </div>

            <!-- GRAVIDANZA E CONTROINDICAZIONI -->
            <div class="section">
                <div class="section-title warning">ü§± GRAVIDANZA & CONTROINDICAZIONI</div>
                <div class="grid-2">
                    <div>
                        <strong>GRAVIDANZA - SICURI:</strong><br>
                        ‚Ä¢ Labetalolo ‚Ä¢ Nifedipina<br>
                        ‚Ä¢ Nitroglicerina ‚Ä¢ Metildopa 250mg<br><br>
                        <strong>CLEVIDIPINA:</strong><br>
                        ‚Ä¢ Dislipidemie gravi ‚Ä¢ Pancreatite<br>
                        ‚Ä¢ Allergia soia/arachidi/uova
                    </div>
                    <div>
                        <strong>GRAVIDANZA - EVITARE:</strong><br>
                        ‚Ä¢ ACE-inibitori ‚Ä¢ Sartani ‚Ä¢ Diuretici<br><br>
                        <strong>LABETALOLO:</strong><br>
                        ‚Ä¢ BPCO/Asma ‚Ä¢ BAV 2-3¬∞ ‚Ä¢ Feocromocitoma<br><br>
                        <strong>CLONIDINA:</strong> Effetto rebound sospensione
                    </div>
                </div>
            </div>

            <!-- NOTE PRATICHE COMPATTE -->
            <div class="section">
                <div class="section-title urgent">üìù NOTE PRATICHE</div>
                <div class="small-text">
                    <strong>Nifedipina SL:</strong> 10mg ripeti 30min (max 40mg/3h) | <strong>Furosemide crisi:</strong> 20mg EV (‚Üì~10mmHg)<br>
                    <strong>Metildopa:</strong> 250mg 2-4√ó/die (max 2g) | <strong>Doxazosina:</strong> 1-2mg‚Üí16mg (ore 8-20 se 2√ó/die)
                </div>
            </div>
        </div>
<div class="back-link">
            <a href="../index.html">‚Üê Torna all'indice principale</a>
        </div>
        <!-- Sezione contatti migliorata -->
        <div class="contatti">
            <p>
                <strong>Contatti:</strong> Per segnalare errori o suggerimenti:<br>
                <span id="email"></span>
            </p>
            <div class="social-links">
                <a href="https://mastodon.social/@fedele9" target="_blank" rel="noopener noreferrer" class="social-link">
                    <svg width="24" height="24" viewBox="0 0 24 24" fill="#6364FF">
                        <path d="M21.327 8.566c0-4.339-2.843-5.61-2.843-5.61-1.433-.658-3.894-.935-6.451-.956h-.063c-2.557.021-5.016.298-6.45.956 0 0-2.843 1.272-2.843 5.61 0 .993-.019 2.181.012 3.441.103 4.243.778 8.425 4.701 9.463 1.809.479 3.362.579 4.612.51 2.268-.126 3.542-.809 3.542-.809l-.075-1.646s-1.621.511-3.441.449c-1.804-.062-3.707-.194-3.999-2.409a4.523 4.523 0 0 1-.04-.621s1.77.433 4.014.536c1.372.063 2.658-.08 3.965-.236 2.506-.299 4.688-1.843 4.962-3.254.434-2.223.398-5.424.398-5.424zm-3.353 5.59h-2.081V9.057c0-1.075-.452-1.62-1.357-1.62-1 0-1.501.647-1.501 1.927v2.791h-2.069V9.364c0-1.28-.501-1.927-1.502-1.927-.905 0-1.357.545-1.357 1.62v5.099H6.026V8.903c0-1.074.273-1.927.823-2.558.566-.631 1.307-.955 2.228-.955.892 0 1.58.343 2.077 1.032l.451.757.452-.757c.497-.689 1.185-1.032 2.077-1.032.92 0 1.662.324 2.228.955.55.631.823 1.484.823 2.558v5.253z"/>
                    </svg>
                    Mastodon
                </a>
                <a href="https://gram.social/Fedele" target="_blank" rel="noopener noreferrer" class="social-link">
        <svg width="24" height="24" viewBox="0 0 24 24" fill="#E1306C">
            <path d="M12 2.163c3.204 0 3.584.012 4.85.07 3.252.148 4.771 1.691 4.919 4.919.058 1.265.069 1.645.069 4.849 0 3.205-.012 3.584-.069 4.849-.149 3.225-1.664 4.771-4.919 4.919-1.266.058-1.644.07-4.85.07-3.204 0-3.584-.012-4.849-.07-3.26-.149-4.771-1.699-4.919-4.92-.058-1.265-.07-1.644-.07-4.849 0-3.204.013-3.583.07-4.849.149-3.227 1.664-4.771 4.919-4.919 1.266-.057 1.645-.069 4.849-.069zm0-2.163c-3.259 0-3.667.014-4.947.072-4.358.2-6.78 2.618-6.98 6.98-.059 1.281-.073 1.689-.073 4.948 0 3.259.014 3.668.072 4.948.2 4.358 2.618 6.78 6.98 6.98 1.281.058 1.689.072 4.948.072 3.259 0 3.668-.014 4.948-.072 4.354-.2 6.782-2.618 6.979-6.98.059-1.28.073-1.689.073-4.948 0-3.259-.014-3.667-.072-4.947-.196-4.354-2.617-6.78-6.979-6.98-1.281-.059-1.69-.073-4.949-.073zM5.838 12a6.162 6.162 0 1 1 12.324 0 6.162 6.162 0 0 1-12.324 0zM12 16a4 4 0 1 1 0-8 4 4 0 0 1 0 8zm4.965-10.405a1.44 1.44 0 1 1 2.881.001 1.44 1.44 0 0 1-2.881-.001z"/>
        </svg>
        Pixelfed
         </a>
                
                <a href="https://github.com/fedele93" target="_blank" rel="noopener noreferrer" class="social-link">
                    <svg width="24" height="24" viewBox="0 0 24 24" fill="#000">
                        <path d="M12 0c-6.626 0-12 5.373-12 12 0 5.302 3.438 9.8 8.207 11.387.599.111.793-.261.793-.577v-2.234c-3.338.726-4.033-1.416-4.033-1.416-.546-1.387-1.333-1.756-1.333-1.756-1.089-.745.083-.729.083-.729 1.205.084 1.839 1.237 1.839 1.237 1.07 1.834 2.807 1.304 3.492.997.107-.775.418-1.305.762-1.604-2.665-.305-5.467-1.334-5.467-5.931 0-1.311.469-2.381 1.236-3.221-.124-.303-.535-1.524.117-3.176 0 0 1.008-.322 3.301 1.23.957-.266 1.983-.399 3.003-.404 1.02.005 2.047.138 3.006.404 2.291-1.552 3.297-1.23 3.297-1.23.653 1.653.242 2.874.118 3.176.77.84 1.235 1.911 1.235 3.221 0 4.609-2.807 5.624-5.479 5.921.43.372.823 1.102.823 2.222v3.293c0 .319.192.694.801.576 4.765-1.589 8.199-6.086 8.199-11.386 0-6.627-5.373-12-12-12z"/>
                    </svg>
                    GitHub
                </a>
            </div>
        </div>
    </div>

    <!-- Navigazione sticky migliorata -->
    <div class="nav-container">
        <button class="nav-button" onclick="scrollToSection('tachiaritmie')">Tachi</button>
        <button class="nav-button" onclick="scrollToSection('antiaritmici')">Antiarit</button>
        <button class="nav-button" onclick="scrollToSection('bradiaritmie')">Bradi</button>
        <button class="nav-button" onclick="scrollToSection('ipertensione')">Ipertens</button>
    </div>

    <!-- Script ottimizzato -->
    <script>
        // Email mascherata
        const nome = "neurologiaperschemi.wolf853";      
        const dominio = "passinbox.com"; 
        const email = nome + "@" + dominio;
        document.getElementById("email").innerHTML = `<a href="mailto:${email}">${email}</a>`;
        
        // Navigazione smooth con offset per header sticky
        function scrollToSection(sectionId) {
            const element = document.getElementById(sectionId);
            if (element) {
                const yOffset = -10;
                const y = element.getBoundingClientRect().top + window.pageYOffset + yOffset;
                window.scrollTo({top: y, behavior: 'smooth'});
            }
        }
        
        // Evidenzia sezione attiva durante lo scroll
        window.addEventListener('scroll', () => {
            const sections = ['tachiaritmie', 'antiaritmici', 'bradiaritmie', 'ipertensione'];
            const buttons = document.querySelectorAll('.nav-button');
            
            let current = '';
            sections.forEach(section => {
                const element = document.getElementById(section);
                if (element) {
                    const rect = element.getBoundingClientRect();
                    if (rect.top <= 100 && rect.bottom >= 100) {
                        current = section;
                    }
                }
            });
            
            buttons.forEach((button, index) => {
                if (sections[index] === current) {
                    button.style.background = 'linear-gradient(135deg, #0d47a1, #1565c0)';
                } else {
                    button.style.background = 'linear-gradient(135deg, #1976d2, #2196f3)';
                }
            });
        });
        
        // Service Worker per PWA (opzionale)
        if ('serviceWorker' in navigator) {
            window.addEventListener('load', () => {
                navigator.serviceWorker.register('/sw.js').catch(() => {});
            });
        }
    </script>
</body>
</html>
